Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump
Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.Read more...
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
thenextweb
Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond D
<img src="https://media.thenextweb.com/2026/05/Novo-Nordisk.avif" width="868" height="488"><br /><p>Novo Holdings, the investment company that controls [...]
Novo Nordisk hands shelved Parkinson’s cell therapy to Zuckerberg-backed
<img src="https://media.thenextweb.com/2026/05/Novo-Nordisk.avif" width="868" height="488"><br /><p>Novo will take an equity stake in Cellular Intellige [...]